| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/06/2000 | CA2321672A1 Caspase-8 interacting proteins |
| 07/05/2000 | EP1016716A2 Dna encoding a growth factor specific for epithelial cells |
| 07/05/2000 | EP1016671A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
| 07/05/2000 | EP1016419A2 Non-invasive localization of a light-emitting conjugate in a mammal |
| 07/05/2000 | EP1016418A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/05/2000 | EP1016416A2 Vaccine against lyme disease and a challenge model for evaluating vaccine efficacy |
| 07/05/2000 | EP1016413A1 Human growth hormone to stimulate mobilization of pluripotent hematopoietic stem cells |
| 07/05/2000 | EP1015886A1 Detection of measles virus-specific antibodies |
| 07/05/2000 | EP1015826A2 Long-term shelf preservation by vitrification |
| 07/05/2000 | EP1015616A2 Intrabody-mediated control of immune reactions |
| 07/05/2000 | EP1015615A1 Targeted gene transfer using g protein coupled receptors |
| 07/05/2000 | EP1015610A2 Medicament for treating a manifested lyme disease |
| 07/05/2000 | EP1015607A1 Dna encoding a ras carboxyl-terminal processing protein |
| 07/05/2000 | EP1015604A1 Human prl-1 phosphatase |
| 07/05/2000 | EP1015602A1 Glutrna gln amidotransferase - a novel essential translational component |
| 07/05/2000 | EP1015596A1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 07/05/2000 | EP1015595A1 Peptides derived from the attachment (g) protein of respiratory syncytial virus |
| 07/05/2000 | EP1015594A1 Attenuated respiratory syncytial viruses |
| 07/05/2000 | EP1015593A1 Hepatitis b virus polypeptides |
| 07/05/2000 | EP1015591A2 Improved method of production of pneumococcal surface proteins |
| 07/05/2000 | EP1015587A1 DcR3 POLYPEPTIDE, A TNFR HOMOLOG |
| 07/05/2000 | EP1015586A2 Tie receptor tyrosine kinase ligand homologues |
| 07/05/2000 | EP1015585A2 Tie ligand homologues |
| 07/05/2000 | EP1015581A1 Insecticidal gene and peptide |
| 07/05/2000 | EP1015579A2 Clostridium toxin, and method for preparing immunogenic compositions |
| 07/05/2000 | EP1015560A1 Modified small rna viruses |
| 07/05/2000 | EP1015496A2 Immuntoxins and methods of inducing immune tolerance |
| 07/05/2000 | EP1015493A1 Novel epithelial tissue targeting agent |
| 07/05/2000 | EP1015489A1 Dendritic cell receptor |
| 07/05/2000 | EP1015487A2 Ligands for discoidin domain receptor tyrosine kinases and complexes thereof |
| 07/05/2000 | EP1015481A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 07/05/2000 | EP1015474A1 Don-1 gene and polypeptides and uses therefor |
| 07/05/2000 | EP1015473A1 CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R) |
| 07/05/2000 | EP1015471A1 Hypoxia-regulated genes |
| 07/05/2000 | EP1015468A1 Follistatin-3 |
| 07/05/2000 | EP1015043A1 Methods for inhibiting rejection of transplanted tissues by bone grafting |
| 07/05/2000 | EP1015036A1 Improvements in or relating to expression of immunogenic substances |
| 07/05/2000 | EP1015033A2 Substituted perylenequinones for use in photodynamic therapy |
| 07/05/2000 | EP1015031A1 Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
| 07/05/2000 | EP1015029A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent |
| 07/05/2000 | EP1015028A2 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 07/05/2000 | EP1015027A2 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this procedure |
| 07/05/2000 | EP1015026A2 Il-12 as an adjuvant for bordetella pertussis vaccines |
| 07/05/2000 | EP1015025A1 T-cell vaccination for the treatment of multiple sclerosis |
| 07/05/2000 | EP1015023A1 Use or a secretion vector for fertility control by oral vaccination |
| 07/05/2000 | EP1015021A2 Agents for combating bacterial meningitis |
| 07/05/2000 | EP1015009A1 Attenuated vif dna immunization cassettes for genetic vaccines |
| 07/05/2000 | EP1015008A1 Compounds and compositions for delivering active agents |
| 07/05/2000 | EP1015003A1 Transgenic autologous t-cell therapy in humans, and related compositions and kits |
| 07/05/2000 | EP1014787A1 Adjuvant for transcutaneous immunization |
| 07/05/2000 | EP0853487B1 Neutralizing monoclonal antibodies to respiratory syncytial virus |
| 07/05/2000 | EP0619839B1 Novel polypeptides for promoting cell attachment |
| 07/05/2000 | EP0577752B1 Human pf4a receptors and their use |
| 07/05/2000 | CN1259141A PRRSV antigenic sites identifying peptide sequences of PRRS virus for use in vaccines or diagnostic assays |
| 07/05/2000 | CN1259052A Aqueous immunologic adjuvant compositions of monophosphoryl lipid A |
| 07/05/2000 | CN1259051A Stabilized human papillomavirus formulations |
| 07/05/2000 | CN1258740A Recombined adhenovirus expressing human interleukin 12 and its preparation and use |
| 07/05/2000 | CN1258739A Recombined adenovirus expressing human interleukin 18 and its preparation and use |
| 07/05/2000 | CN1258738A Recombined adenovirus expressing the stimulating factor of human granulocyte-macrophage colony and its preparation and use |
| 07/04/2000 | US6084086 Polynucleotide which codes for a polypeptide from the two component signal transduction system of staphylococcus aureus; for diagnosis of bacterial infections; for bactericides, bacteriostats |
| 07/04/2000 | US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6084067 CTLA4/CD28 ligands and uses therefor |
| 07/04/2000 | US6083929 Immunogens and tumor markers; detection of cancer |
| 07/04/2000 | US6083925 Nucleic acid respiratory syncytial virus vaccines |
| 07/04/2000 | US6083924 DnaB of staphylococcus aureus |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083756 Identifying infant's susceptibility by detecting helicobacter pylori in sample of blood, saliva, dental plaque, feces or exhaled air collected from infant's mother, close relative, or person expected to come into close bodily contact |
| 07/04/2000 | US6083749 DNA encoding a human serotonin receptor (5-HT4B) and uses thereof |
| 07/04/2000 | US6083743 Dna and amino acid sequences; for diagnosis and treatment of infections including otitis media, epiglottitis, pneumonia, and tracheobronchitis; for immunogenic compositions/vaccines |
| 07/04/2000 | US6083724 Recombinant avian interferon-gamma (IFN-γ) |
| 07/04/2000 | US6083722 Borrelia antigen |
| 07/04/2000 | US6083713 Nucleotide sequences coding binding polypeptide for the terminal domain of the amyloid precursor protein; for the diagnosis and design of drugs for treatment of alzheimer's disease |
| 07/04/2000 | US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein |
| 07/04/2000 | US6083703 Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes |
| 07/04/2000 | US6083523 Implantable biocompatable immunoisolatory vehicle for delivery of selected therapeutic products |
| 07/04/2000 | US6083513 Synergistic immunological adjuvant formulation comprising a glycopeptide, an amino acid complex, a lipid substance, and an antigen; for enhancing the natural immune response in animals and humans |
| 07/04/2000 | US6083512 Administered to cattle |
| 07/04/2000 | US6083511 Isolated equine herpesvirus-4 (ehv-4) or gh or gc polypeptides and antigenic fragments; vaccine for the protection of horses against ehv-4 infection |
| 07/04/2000 | US6083505 Immunogen/vaccine adjuvant composition containing an immunogen in an amount effective to stimulate an immune response and as a vaccine adjuvant a 1h-imidazo(4,5-c)quinolin-4-amine in an amount effective to increase the immune response to the |
| 07/04/2000 | US6083504 Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) |
| 07/04/2000 | US6083503 Administering an antigen specifically recognized by t cells to cause the t cells that specifically recognize the antigen to express interleukin-2 or il-2 receptors, such that the t cell immune response to the antigen is inhibited |
| 07/04/2000 | US6083502 Methods for detecting the antigen and its expression level as an indication of the presence of tumor cells |
| 07/04/2000 | US6083478 Consists of a cytotoxic radionuclide and a homodimer comprising two heavy chains encoded by the expression vector designated cd4-igg2-pcdna1 (atcc no. 40952) |
| 07/04/2000 | US6083477 Useful therapeutic reagents for treating leukemias and lymphomas;conjugate of a non-immunogenic rnase or a therapeutic radionuclide that is an alpha-emitter or a beta-emitter and a cell-specific cytokine |
| 07/04/2000 | CA2103021C Recombinant dna coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence |
| 07/04/2000 | CA1341042C Y, & t cell receptor and methods for detection |
| 06/29/2000 | WO2000037942A1 Conjugates for detecting viruses that cause diseases of the respiratory tract and use thereof |
| 06/29/2000 | WO2000037664A1 Method for preparing suspension of stable posiplexes |
| 06/29/2000 | WO2000037650A1 Hepatitis y virus |
| 06/29/2000 | WO2000037648A1 Protective antigen of group a streptococci (spa) |
| 06/29/2000 | WO2000037646A2 Group b streptococcus proteins, and their use |
| 06/29/2000 | WO2000037643A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 06/29/2000 | WO2000037640A2 Compositions and methods for the treatment of tumor |
| 06/29/2000 | WO2000037634A2 Novel polypeptides and nucleic acids encoding same |
| 06/29/2000 | WO2000037613A2 Human akt-3 |
| 06/29/2000 | WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE |
| 06/29/2000 | WO2000037610A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants |
| 06/29/2000 | WO2000037609A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 06/29/2000 | WO2000037504A2 Human monoclonal antibodies to ctla-4 |